Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group Revenue

Kingworld Medicines Group had revenue of 275.37M CNY in the half year ending June 30, 2026, a decrease of -47.66%. This brings the company's total for the last twelve months to 787.87M, down -16.17% year-over-year. In the year 2025, Kingworld Medicines Group had annual revenue of 917.34M, down -13.55%. That makes Kingworld Medicines Group the 21,512th largest company in the world by revenue and 1,257th in Hong Kong.

• Revenue (ttm): 787.87M CNY
• Revenue Growth: -16.17%
• P/S Ratio: 0.25
• Revenue / Employee: 1.11M CNY
• Employees: 711
• Market Cap: 231.06M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Distribution Sales of Pharmaceutical and Healthcare Products - PRC 753.35M 73.3%
• Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices - PRC 259.06M 25.2%
• Distribution Sales of Pharmaceutical and Healthcare Products - Hong Kong 15.22M 1.5%

By Geography

Chart

• PRC (Excluding Hong Kong) 656.06M 71.5%
• The United States of America 100.96M 11.0%
• Others 51.46M 5.6%
• Germany 29.90M 3.3%
• Italy 27.00M 2.9%
• France 20.15M 2.2%
• Hong Kong 16.99M 1.9%
• Other 14.83M 1.6%

Fiscal year ended Dec 31, 2025 See the full Kingworld Medicines Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	917.34M	-143.74M	-13.55%
Dec 31, 2024	1.06B	-17.58M	-1.63%
Dec 31, 2023	1.08B	120.96M	12.63%
Dec 31, 2022	957.70M	110.32M	13.02%
Dec 31, 2021	847.39M	102.00M	13.68%

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 23, 2026

Data Sources Report a data error